FDANonrulemakingFDA-2026-N-5479

Who commented on this docket

Testosterone Use in Menopausal Women; Public Workshop

13 organizations filed 13 public comments on Testosterone Use in Menopausal Women; Public Workshop, at the Food and Drug Administration. The comment window closed 17d ago.

Organizations
13
Comments
13
RIN
—
Comment window
closed 17d ago

Abstract

OPEN

Commenters (13)

  • Acrux DDS Pty Ltdunverified attribution
    1 filing · confidence 70%
  • Adelaide Universityunverified attribution
    1 filing · confidence 70%
  • Ailse Oncology Ltd.unverified attribution
    1 filing · confidence 70%
  • American Association of Clinical Endocrinologytrade assoc.
    1 filing · confidence 85%
  • Health Without Risk LLCunverified attribution
    1 filing · confidence 70%
  • Hims & Hers Health Inc.unverified attribution
    1 filing · confidence 70%
  • International Society for the Study of Women's Sexual Healthtrade assoc.
    1 filing · confidence 85%
  • LIPOCINE INC.unverified attribution
    1 filing · confidence 70%
  • PharmedOut at Georgetown University Medical Centerunverified attribution
    1 filing · confidence 70%
  • RRM Foundationtrade assoc.
    1 filing · confidence 85%
  • The Netherlands Association for Women's Intereststrade assoc.
    1 filing · confidence 85%
  • The Netherlands Association for Women's Interests Women's Work and Equal Citizenshiptrade assoc.
    1 filing · confidence 85%
View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.